| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| TEVA Teva Pharmaceutical Industries Limited | 116,224,760,382.75 | 437,552,039,088.0 | 1,267,406,367,872.85 |
| BHC Bausch Health Companies Inc. | 58,032,883,091.25 | 207,392,034,806.1 | 788,420,440,199.7 |
| RDY Dr. Reddy's Laboratories Limited | 3,691,265,795.95 | 100,656,853,599.89 | 193,459,384,962.76 |
| 1795 美時 | 6,325,432,000 | 25,659,301,000 | 108,585,630,000 |
| AMPH Amphastar Pharmaceuticals, Inc. | 7,110,665,818.94 | 20,063,509,928.39 | 55,449,736,118.63 |
| 6472 保瑞 | 8,431,018,000 | 24,395,699,000 | 52,077,131,000 |
| SUPN Supernus Pharmaceuticals, Inc. | 5,722,296,663.52 | 23,006,333,580.81 | 45,412,209,664.97 |
| BBIO BridgeBio Pharma, Inc. | 21,556,783,457.14 | 34,760,520,414.58 | 38,708,696,194.02 |
| TSHA Taysha Gene Therapies, Inc. | 14,481,414,350.65 | 14,673,065,959.63 | 14,959,223,721.24 |
| 3705 永信 | 1,681,311,000 | 7,568,539,000 | 13,176,178,000 |
| 1720 生達 | 2,014,373,000 | 5,775,065,000 | 12,315,901,000 |
| 4120 友華 | 1,545,691,000 | 4,035,955,000 | 11,750,301,000 |
| ASMB Assembly Biosciences Inc | 1,026,657,349.85 | 10,429,319,961.92 | 10,520,073,851.42 |
| PSNL Personalis, Inc. | 2,988,073,401.82 | 7,792,369,351.93 | 9,925,530,939.01 |
| 4747 強生* | 261,729,000 | 602,886,000 | 2,558,703,000 |
| 6461 益得 | 95,420,000 | 370,571,000 | 2,295,483,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | 529,832,272.91 | 1,624,316,548.59 | 1,709,378,445.73 |
| CPHI China Pharma Holdings Inc | 9,694,512.37 | 63,808,188.42 | 1,421,722,958.75 |
| 6130 上亞科技 | 75,442,000 | 178,444,000 | 735,886,000 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例